檢索結果 - Xiajing Che
- Showing 1 - 4 results of 4
-
1
Sodium glucose co-transporter 2 (SGLT2) inhibition via dapagliflozin improves diabetic kidney disease (DKD) over time associatied with increasing effect on the gut microbiota in db... 由 Jiajia Wu, Yan Chen, Huinan Yang, Leyi Gu, Zhaohui Ni, Shan Mou, Jianxiao Shen, Xiajing Che
出版 2023Artigo -
2
-
3
-
4
Urgent-Start Peritoneal Dialysis and Hemodialysis in ESRD Patients: Complications and Outcomes 由 Haijiao Jin, Wei Fang, Mingli Zhu, Zanzhe Yu, Yan Fang, Hao Yan, Minfang Zhang, Qin Wang, Xiajing Che, Yuanyuan Xie, Jiaying Huang, Chunhua Hu, Zhang Hai-fen, Shan Mou, Zhaohui Ni
出版 2016Artigo
相關主題
Internal medicine
Medicine
Biochemistry
Biology
Acute kidney injury
Cancer research
Cell biology
Diabetes mellitus
Endocrinology
Immunology
16S ribosomal RNA
Apoptosis
Dapagliflozin
Dialysis
End stage renal disease
Fermentation
Fibrosis
Firmicutes
Food science
Gene
Gut flora
Hemodialysis
In vitro
Inflammasome
Inflammation
Intensive care medicine
Kidney
Kidney disease
Kinase
Lactobacillus